For the Inventor, By the Inventor

Enter inventor name

Shanghai, China

Wenyuan Qian

USPTO Granted Patents = 19 (Patent Applications = 10)

CIPO Patents = 8 (Patent Applications = 7)

EPO Patents = 16 (Patent Applications = 30)

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

Medshine Discovery Inc.

Wuxi Biocity Biopharmaceutics Co., Ltd.

Kpc Pharmaceuticals, Inc.

Zhuhai United Laboratories Co., Ltd.

Guangzhou Joyo Pharmatech Co., Ltd.

Cstone Pharmaceuticals (suzhou) Co., Ltd.

Cstone Pharmaceuticals (shanghai) Co., Ltd.

Cstone Pharmaceuticals

Shijiazhuang Sagacity New Drug Development Company, Ltd.

Cisen Pharmaceutical Co., Ltd.

where one patent can have more than one assignee

Years Active: 2019-2025

where 'Filed Patents' based on already Granted Patents

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12486266 - Crystalline form of JAK inhibitor and application thereof (2025-12-02),

2. 12479839 - Crystalline form of ATR inhibitor and use thereof (2025-11-25),

3. 12428391 - Dimethylsulfoximine derivative (2025-09-30),

4. 12391653 - Salt form and crystal form of mutant IDH1 inhibitor and preparation method therefor (2025-08-19),

5. 12351590 - Pyrrolopyrimidine compound and use thereof (2025-07-08),

6. 12291536 - Crystal form of Wee1 inhibitor compound and use thereof (2025-05-06),

7. 12180184 - Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereof (2024-12-31),

8. 11919896 - [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof (2024-03-05),

9. 11634424 - Diazaindole derivative and use thereof as CHK1 inhibitor (2023-04-25),

10. 11613545 - Macrocyclic compound serving as Wee1 inhibitor and applications thereof (2023-03-28),

11. 11434232 - ATR inhibitor and application thereof (2022-09-06),

12. 11407717 - Benzimidazole derivatives and use thereof as IDH1 inhibitors (2022-08-09),

13. 11384065 - Heterocyclic compound as CSF-1R inhibitor and use thereof (2022-07-12),

14. 11345682 - Polymorph of HDAC6-selective inhibitor and application thereof (2022-05-31),

15. 11299475 - Prostacyclin receptor agonist (2022-04-12),

Title: Inventor Wenyuan Qian

Introduction: Wenyuan Qian is a renowned inventor based in Shanghai, China, known for his groundbreaking contributions to various technological fields.

Latest Patents: Wenyuan Qian holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Wenyuan Qian has worked with leading research institutions and multinational companies, consistently pushing the boundaries of innovation and technology.

Collaborations: Throughout his career, Wenyuan Qian has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of creativity and excellence in his projects.

Conclusion: Wenyuan Qian's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…